Ademetionine 400 mg Tablet is a unique therapeutic agent that Salvus Pharma is proud to offer via our exclusive PCD Pharma franchise in Bengaluru. This product is designed to meet a significant, two-fold clinical challenge growing in the city.
The Clinical Challenge: Bengaluru's fast-paced lifestyle is contributing to a rise in chronic liver conditions. Simultaneously, an active and aging population is facing a parallel increase in osteoarthritis and joint health issues. Physicians are actively seeking a reliable, high-quality medication that can address these distinct patient needs.
The Therapeutic Solution: Adysil 400 Our Adysil 400 (Ademetionine 400 mg Tablet) is the ideal solution. It is a trusted hepato-protectant that aids in liver detoxification and a proven chondroprotective agent that supports cartilage health and reduces joint pain.
The Business Solution for Bengaluru Partners: This dual-action mechanism translates into a powerful business opportunity:
- Access Two Key Markets: Promote a single product to both Gastroenterologists and Orthopedic specialists.
- Double Your Revenue Potential: Capitalize on two separate, high-demand patient streams.
- Build a Diverse Portfolio: Start with a versatile product that establishes your reputation for quality in multiple therapeutic areas.
Salvus Pharma is offering exclusive monopoly rights for this opportunity in Bengaluru, backed by our WHO-GMP certified quality and full marketing support.
Secure This Dual-Market Franchise: Contact us at +91 9888902349 or marketing@salvuspharma.in to learn more.
